EUVIMEDEUVIMED entdecken
Übersichtsarbeit

How extracellular vesicles contribute to pulmonary fibrosis: miRNA-mediated mechanisms, diagnostic potential, and emerging therapeutic strategies

Xinyi Liu, Zhenzhen Zhao, Lijuan Zhu, Wen Zhang, Jinhan Zhou, Xiaodan Wu, Lan Jiang

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-12858-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Xinyi Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Yijishan-Qizhi Medical Embodied Intelligence Joint Laboratory, Yijishan Hospital of Wannan Medical University, Wuhu, 241000, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, MicroRNAs, Pulmonary Fibrosis. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Health Research Program of Anhui, Scientific Research Project of Anhui Provincial Department of Education, National Undergraduate Training Program on Innovation and Entrepreneurship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis (PF) is a progressive interstitial lung disease driven by excessive fibroblast activation and extracellular matrix (ECM) deposition, for which pirfenidone and nintedanib slow but do not halt disease progression. Extracellular vesicles (EVs)-lipid bilayer-enclosed nanoparticles that shuttle microRNAs (miRNAs), proteins, and lipids between cells-are increasingly recognized as important mediators and potential modulators of fibrotic remodeling. On the pathogenic side, epithelial- and immune-cell-derived EVs can deliver pro-fibrotic miRNAs (e.g., miR-494-3p) that regulate transforming growth factor beta (TGF-β)/Smad and Wnt/β-catenin signaling, promoting fibroblast-to-myofibroblast transition and ECM accumulation. Conversely, selected mesenchymal stem cell-derived EV (MSC-EV) preparations have demonstrated anti-fibrotic effects in preclinical models through modulation of TGF-β/Smad signaling, M2 macrophage polarization, mitochondrial function, and epithelial-mesenchymal transition; a phase I clinical study has provided initial safety evidence for nebulized administration, although therapeutic efficacy in PF has not yet been established. Beyond MSC-EVs, plant-derived and milk-derived EVs have emerged as potential delivery platforms, although their applications remain largely preclinical. Meanwhile, EVs isolated from plasma, bronchoalveolar lavage fluid, sputum, and urine carry disease-associated molecular signatures that may serve as candidate biomarkers for PF detection or monitoring, but require further clinical validation. This review synthesizes recent evidence on the dual roles of EVs in PF pathogenesis and therapy, evaluates their potential diagnostic utility, and discusses translational hurdles-including cargo standardization, targeted delivery, and scalable manufacturing-that must be overcome for clinical adoption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesMicroRNAsPulmonary FibrosisHumansAnimalsMesenchymal Stem CellsTransforming Growth Factor betaSignal Transduction

Stichwörter der Autor:innen

Drug DeliveryExtracellular VesiclesMesenchymal Stem CellsPulmonary fibrosis

Substanzen

MicroRNAsTransforming Growth Factor beta

Autor:innen und Institutionen

  • Yijishan-Qizhi Medical Embodied Intelligence Joint Laboratory, Yijishan Hospital of Wannan Medical University, Wuhu, 241000, China.
  • Clinical Medical Research Center, Central Laboratory, Fuzhou University Affiliated Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, School of Medicine, Fuzhou, 350001, Fujian, China. w…
  • Yijishan-Qizhi Medical Embodied Intelligence Joint Laboratory, Yijishan Hospital of Wannan Medical University, Wuhu, 241000, China. jianglanhi@163.com.
  • Clinical Medical Research Center, Central Laboratory, Fuzhou University Affiliated Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, School of Medicine, Fuzhou, 350001, Fujian, China. j…

Förderung

  • Health Research Program of Anhui
  • Scientific Research Project of Anhui Provincial Department of Education
  • National Undergraduate Training Program on Innovation and Entrepreneurship
  • Anhui Province College Students Innovation and Entrepreneurship Training Program Project

Zitieren

APA

Liu, X., Zhao, Z., Zhu, L., Zhang, W., Zhou, J., Wu, X., & Jiang, L. (2026). How extracellular vesicles contribute to pulmonary fibrosis: miRNA-mediated mechanisms, diagnostic potential, and emerging therapeutic strategies. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-12858-9

Vancouver

Liu X, Zhao Z, Zhu L, Zhang W, Zhou J, Wu X, et al. How extracellular vesicles contribute to pulmonary fibrosis: miRNA-mediated mechanisms, diagnostic potential, and emerging therapeutic strategies. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-12858-9

BibTeX
@article{Liu2026,
  author = {Liu, Xinyi and Zhao, Zhenzhen and Zhu, Lijuan and Zhang, Wen and Zhou, Jinhan and Wu, Xiaodan and Jiang, Lan},
  title = {How extracellular vesicles contribute to pulmonary fibrosis: miRNA-mediated mechanisms, diagnostic potential, and emerging therapeutic strategies},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-12858-9}
}
Kostenlos starten →